Johns Hopkins HIV Guide
Sulfadiazine
INDICATIONS
FDA
FDA
- CNS and ocular toxoplasmosis (in combination with pyrimethamine)
- FDA indicated, but not generally recommended:
- Chancroid
- Trachoma
- Inclusion conjunctivitis
- Prophylaxis of meningococcal meningitis when sulfonamide-sensitive group A strains known to prevail
- Meningococcal meningitis
- Acute otitis media due to H. influenzae(in combination with PCN)
- Prophylaxis against recurrences of rheumatic fever (alternative to penicillin)
- H. influenzae meningitis (in combination with streptomycin)
- UTI (including pyelonephritis)
- Malaria due to chloroquine-resistant P. falciparum malaria (in combination with quinine and pyrimethamine)
- Nocardiosis
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: October 2, 2017
Citation
Smith, Janessa, and Paul A Pham. "Sulfadiazine." Johns Hopkins HIV Guide, 2017. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545196/0.0/Sulfadiazine.
Smith J, Pham PA. Sulfadiazine. Johns Hopkins HIV Guide. 2017. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545196/0.0/Sulfadiazine. Accessed September 25, 2023.
Smith, J., & Pham, P. A. (2017). Sulfadiazine. In Johns Hopkins HIV Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545196/0.0/Sulfadiazine
Smith J, Pham PA. Sulfadiazine [Internet]. In: Johns Hopkins HIV Guide. ; 2017. [cited 2023 September 25]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545196/0.0/Sulfadiazine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Sulfadiazine
ID - 545196
A1 - Smith,Janessa,Pharm.D., BCPS
AU - Pham,Paul,Pharm.D.
Y1 - 2017/10/02/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545196/0.0/Sulfadiazine
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
